✦ LIBER ✦

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of extended-release niacin/laropi

✍ James McKenney; Harold Bays; Michael Koren; Christie M. Ballantyne; John F. Paol 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 404 KB

SAFETY PROFILE OF EXTENDED-RELEASE NIACI

✍ McKenney, J.; Bays, H.; Koren, M.; Ballantyne, C.; Maccubbin, D.; Mitchel, Y.; B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 218 KB

EXTENDED-RELEASE NIACIN/LAROPIPRANT LOWE

✍ Andrew G. Bostom; Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A. H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The Lipid-Altering Effects of Extended-R

✍ Harold Edward Bays; Alexandra MacLean; Arvind Shah; Christine McCrary Sisk; Qian 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 38 KB

Effects of coadministered extended-relea

✍ Christie Ballantyne; Gilbert Gleim; Nancy Liu; Christine McCrary Sisk; Amy O. Jo 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 574 KB

Efficacy and tolerability of extended-re

✍ Harold E. Bays; Arvind Shah; Jianxin Lin; Christine McCrary Sisk; John F. Paolin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 278 KB